On the Biocompatibility and Teat Retention of In Situ Gelling Intramammary Formulations: Cattle Mastitis Prevention and Treatment.

Pharmaceutics · 2021 · PMC8539992 · PMID 34684025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

A decreasing trend in cell viability was observed upon exposure of the MAC-T cells to increasing concentrations of ALG 1 and ALG 2 formulations, with significant reductions seen at 1 mg/mL for both formulations and at 0.5 mg/mL for ALG2.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.